Victory Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
Victory Capital Management's LAB Position: Q3 2026 in Review
Victory Capital Management reduced its Standard BioTools (LAB) stake by 0.83% in Q3 2026, selling an estimated $277 and leaving 43,045 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2466.
Victory Capital Management first reported a position in LAB in Q3 2019 and has held it in 17 quarters since. The position peaked at $100K in Q1 2024. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- Victory Capital Management held 43,045 shares of Standard BioTools worth $31.9K as of Q3 2026.
- Victory Capital Management sold 360 Standard BioTools shares in Q3 2026, an estimated $277.
- Standard BioTools made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2466 holding.
- Victory Capital Management first reported a position in Standard BioTools in Q3 2019 and has held it in 17 quarters since.
- Victory Capital Management's Standard BioTools position peaked at $100K in Q1 2024.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.